FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|October 5, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 5, 2021
Author(s)Sydney Jennings
Advertisement
How widespread is the Delta variant (B.1.617.2) in the US?
According to early estimates from the
The CDC estimates for the week ending on September 25, 2021, the 5 states with the highest unweighted proportion of new cases attributed to the SARS-CoV-2 Delta variant are:
1. Vermont: 100%
2. Washington: 99.46%
3. Delaware: 99.41%
4. Minnesota: 99.16%
5. Massachusetts: 99.16%
2. Washington: 99.46%
3. Delaware: 99.41%
4. Minnesota: 99.16%
5. Massachusetts: 99.16%
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, October 5, 2021, at 2:11 PM, EDT:
• 65% of total US population has received at least 1 dose
• 56% of total US population is fully vaccinated
• 56% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 71.1%
2. Vermont: 69.8%
3. Connecticut: 69.1%
4. Rhode Island: 68.8%
5. Maine: 68.7%
2. Vermont: 69.8%
3. Connecticut: 69.1%
4. Rhode Island: 68.8%
5. Maine: 68.7%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, October 5, 2021 at 3:21 PM, EDT, there have been:
• 43 909 490 confirmed cases and
• 704 550 deaths
• 704 550 deaths
The 5 states with the highest total confirmed cases are:
1. California: 4 749 478
2. Texas: 4 100 078
3. Florida: 3 620 106
4. New York: 2 446 333
5. Illinois: 1 641 052
2. Texas: 4 100 078
3. Florida: 3 620 106
4. New York: 2 446 333
5. Illinois: 1 641 052
Deaths: California has the highest number of deaths due to COVID-19 with 69 477 reported fatalities, followed by Texas with 66 309 and New York with 55 503.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 235 661 953 confirmed cases, 4 813 797 deaths, and 6 342 172 800 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
EASD 2026: The combination of semaglutide/cagrilintide altered food-cue responses and showed a 22.4% estimated weight difference vs placebo; separate data found less organ fat in type 2 diabetes.
The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Advertisement
Advertisement
Trending on Patient Care Online
1
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
2
FDA Grants Priority Review to Elinzanetant for VMS in HR+ Breast Cancer Patients on Endocrine Therapy
3
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
4
CagriSema Alters Food-Cue Responses, Reduces Organ Fat in New Analyses
5